Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
October 21 2022 - 05:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2022
Commission File Number: 001-34541
GLOBAL CORD BLOOD CORPORATION
(Translation of registrant’s name into English)
48th Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong S.A.R.
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Form
20-F x Form 40-F
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ¨
Global Cord Blood Corporation JPL Responses to Common
Questions
On October 20, 2022, Margot MacInnis and John Royle of Grant
Thornton Specialist Services (Cayman) Limited, and Chow Tsz Nga
Georgia of Grant Thornton Recovery & Reorganisation Limited, as
joint provisional liquidators (the “JPLs”) of Global Cord Blood
Corporation (the “Company”) provided responses to common questions
from investors about the provisional liquidation of the Company.
The JPLs’ responses to the common questions are attached hereto as
Exhibit 99.1 and additionally will be posted to the Company's new
website referenced below.
Company Website
The Company’s former website domain,
globalcordbloodcorp.com, was deactivated on an unspecified
date and time at the instruction of persons who are unknown to the
JPLs. After they were appointed and before the site was
deactivated, the JPLs made a backup of the content formerly hosted
on the website and have now restored that content to a new domain
within the JPLs’ control. The new domain is
globalcordbloodcorporation.com and is now functional.
Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
GLOBAL
CORD BLOOD CORPORATION |
|
|
|
|
By: |
/s/
Margot MacInnis |
|
Name: |
Margot
MacInnis |
|
Title: |
Joint
Provisional Liquidator by Order of the Grand Court of the Cayman
Islands |
Dated: October 21, 2022
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Jan 2023 to Feb 2023
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Feb 2022 to Feb 2023